Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment.

Drug Des Devel Ther · 2026 · PMC13243140 · PMID 42266512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While the VS (7.5 entries) and CIS (6 entries) groups showed a trend toward reduced activity, neither group differed significantly from the control group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.